Business
Press Release Nov 30 2023
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 30, 2023, titled "Eugia Pharma, a 100% subsidiary receives USFDA approval for Budesonide Inhalation Suspension".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 30, 2023, titled \"Eugia Pharma, a 100% subsidiary receives USFDA approval for Budesonide Inhalation Suspension\". View Attachment","length":367,"tagName":"div"}]